Literature DB >> 24925328

Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging.

Leslee J Shaw1, Daniel S Berman2, Michael H Picard3, Matthias G Friedrich4, Raymond Y Kwong5, Gregg W Stone6, Roxy Senior7, James K Min8, Rory Hachamovitch9, Marielle Scherrer-Crosbie3, Jennifer H Mieres10, Thomas H Marwick11, Lawrence M Phillips12, Farooq A Chaudhry13, Patricia A Pellikka14, Piotr Slomka15, Andrew E Arai16, Ami E Iskandrian17, Timothy M Bateman18, Gary V Heller19, Todd D Miller14, Eike Nagel20, Abhinav Goyal21, Salvador Borges-Neto22, William E Boden23, Harmony R Reynolds12, Judith S Hochman12, David J Maron24, Pamela S Douglas25.   

Abstract

The lack of standardized reporting of the magnitude of ischemia on noninvasive imaging contributes to variability in translating the severity of ischemia across stress imaging modalities. We identified the risk of coronary artery disease (CAD) death or myocardial infarction (MI) associated with ≥10% ischemic myocardium on stress nuclear imaging as the risk threshold for stress echocardiography and cardiac magnetic resonance. A narrative review revealed that ≥10% ischemic myocardium on stress nuclear imaging was associated with a median rate of CAD death or MI of 4.9%/year (interquartile range: 3.75% to 5.3%). For stress echocardiography, ≥3 newly dysfunctional segments portend a median rate of CAD death or MI of 4.5%/year (interquartile range: 3.8% to 5.9%). Although imprecisely delineated, moderate-severe ischemia on cardiac magnetic resonance may be indicated by ≥4 of 32 stress perfusion defects or ≥3 dobutamine-induced dysfunctional segments. Risk-based thresholds can define equivalent amounts of ischemia across the stress imaging modalities, which will help to translate a common understanding of patient risk on which to guide subsequent management decisions.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiac imaging; ischemia; prognosis

Mesh:

Year:  2014        PMID: 24925328      PMCID: PMC4128344          DOI: 10.1016/j.jcmg.2013.10.021

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  64 in total

1.  ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine.

Authors:  Pamela S Douglas; Bijoy Khandheria; Raymond F Stainback; Neil J Weissman; Eric D Peterson; Robert C Hendel; Raymond F Stainback; Michael Blaivas; Roger D Des Prez; Linda D Gillam; Terry Golash; Loren F Hiratzka; William G Kussmaul; Arthur J Labovitz; JoAnn Lindenfeld; Frederick A Masoudi; Paul H Mayo; David Porembka; John A Spertus; L Samuel Wann; Susan E Wiegers; Ralph G Brindis; Pamela S Douglas; Robert C Hendel; Manesh R Patel; Eric D Peterson; Michael J Wolk; Joseph M Allen
Journal:  J Am Coll Cardiol       Date:  2008-03-18       Impact factor: 24.094

2.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

3.  Prognostic value of exercise stress test and dobutamine stress echo in patients with known coronary artery disease.

Authors:  Francesca Innocenti; Francesca Caldi; Irene Tassinari; Chiara Agresti; Costanza Burgisser; Francesco Fattirolli; Giorgio Jacopo Baldereschi; Niccolò Marchionni; Giulio Masotti; Riccardo Pini
Journal:  Echocardiography       Date:  2008-11-01       Impact factor: 1.724

4.  Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention.

Authors:  Grace A Lin; R Adams Dudley; F L Lucas; David J Malenka; Eric Vittinghoff; Rita F Redberg
Journal:  JAMA       Date:  2008-10-15       Impact factor: 56.272

5.  Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade.

Authors:  V Bodi; J Sanchis; M P Lopez-Lereu; J Nunez; L Mainar; J V Monmeneu; V Ruiz; E Rumiz; O Husser; D Moratal; J Millet; F J Chorro; A Llacer
Journal:  Heart       Date:  2008-04-01       Impact factor: 5.994

6.  Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease.

Authors:  Kirkeith Lertsburapa; Alan W Ahlberg; Timothy M Bateman; Deborah Katten; Lyndy Volker; S James Cullom; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2008-09-12       Impact factor: 5.952

7.  Effects of age, gender, obesity, and diabetes on the efficacy and safety of the selective A2A agonist regadenoson versus adenosine in myocardial perfusion imaging integrated ADVANCE-MPI trial results.

Authors:  Manuel D Cerqueira; Patricia Nguyen; Peter Staehr; S Richard Underwood; Ami E Iskandrian
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

8.  Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease.

Authors:  L I Olmos; H Dakik; R Gordon; J K Dunn; M S Verani; M A Quiñones; W A Zoghbi
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

9.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

10.  Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry.

Authors:  Leslee J Shaw; Richard E Shaw; C Noel Bairey Merz; Ralph G Brindis; Lloyd W Klein; Brahmajee Nallamothu; Pamela S Douglas; Ronald J Krone; Charles R McKay; Peter C Block; Kathleen Hewitt; William S Weintraub; Eric D Peterson
Journal:  Circulation       Date:  2008-03-31       Impact factor: 29.690

View more
  47 in total

Review 1.  Serial imaging and outcome prediction.

Authors:  Ami E Iskandrian; Christopher P Roth; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-10-30       Impact factor: 5.952

2.  Primum non nocere….

Authors:  James K Min
Journal:  J Nucl Cardiol       Date:  2015-12-24       Impact factor: 5.952

3.  Prognostic value of a new semiquantitative score system for adenosine stress myocardial perfusion by CMR.

Authors:  Sonia Gómez-Revelles; Xavier Rossello; José Díaz-Villanueva; Ignacio López-Lima; Esteban Sciarresi; Mariano Estofán; Francesc Carreras; Sandra Pujadas; Guillem Pons-Lladó
Journal:  Eur Radiol       Date:  2018-11-07       Impact factor: 5.315

Review 4.  Stress echocardiography: what is new and how does it compare with myocardial perfusion imaging and other modalities?

Authors:  Marysia S Tweet; Adelaide M Arruda-Olson; Nandan S Anavekar; Patricia A Pellikka
Journal:  Curr Cardiol Rep       Date:  2015-06       Impact factor: 2.931

5.  Impact of the ISCHEMIA Trial on Stress Nuclear Myocardial Perfusion Imaging.

Authors:  Venkatesh L Murthy; Timothy M Bateman; Wengen Chen; Saurabh Malhotra; Edward J Miller; Terrence D Ruddy; Vasken Dilsizian
Journal:  J Nucl Med       Date:  2020-07       Impact factor: 10.057

6.  The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging.

Authors:  Shazia T Hussain; Geraint Morton; Kalpa De Silva; Roy Jogiya; Andreas Schuster; Matthias Paul; Divaka Perera; Eike Nagel
Journal:  Clin Res Cardiol       Date:  2016-10-20       Impact factor: 5.460

7.  Value of gated-SPECT MPI for ischemia-guided PCI of non-culprit vessels in STEMI patients with multivessel disease after primary PCI.

Authors:  Lawrence M Phillips; João V Vitola; Leslee J Shaw; Raffaele Giubbini; Ganesan Karthikeyan; Erick Alexanderson; Maurizio Dondi; Diana Paez; Amalia Peix
Journal:  J Nucl Cardiol       Date:  2018-08-01       Impact factor: 5.952

8.  Left ventricular ejection fraction and presence of myocardial necrosis assessed by cardiac magnetic resonance imaging correctly risk stratify patients with stable coronary artery disease: a multi-center all-comers trial.

Authors:  Dominik Buckert; Sebastian Kelle; Sebastian Buss; Grigorios Korosoglou; Rolf Gebker; Ralf Birkemeyer; Wolfgang Rottbauer; Hugo Katus; Burkert Pieske; Peter Bernhardt
Journal:  Clin Res Cardiol       Date:  2016-10-13       Impact factor: 5.460

9.  Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease does not effectively identify revascularization candidates.

Authors:  Harmony R Reynolds; Michael H Picard; Judith S Hochman
Journal:  Circ Cardiovasc Imaging       Date:  2015-05       Impact factor: 7.792

Review 10.  Imaging the myocardial ischemic cascade.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David A Bluemke; Menko Jan de Boer; Jens Bremerich; Ernest V Garcia; Matthias Gutberlet; Pim van der Harst; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond Y Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Riemer H J A Slart; Vinod Thourani; Rozemarijn Vliegenthart; Bernd J Wintersperger
Journal:  Int J Cardiovasc Imaging       Date:  2018-03-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.